Literature DB >> 14990587

My approach to oncocytic tumours of the thyroid.

S L Asa1.   

Abstract

The traditional approach to oncocytic thyroid lesions classified these as a separate entity, and applied criteria that are somewhat similar to those used for follicular lesions of the thyroid. In general, the guidelines to distinguish hyperplasia from neoplasia, and benign from malignant were crude and unsubstantiated by scientific evidence. In fact, there is no basis to separate oncocytic lesions from other classifications of thyroid pathology. The factors that result in mitochondrial accumulation are largely unrelated to the genetic events that result in proliferation and neoplastic transformation of thyroid follicular epithelial cells. The concept of classifying oncocytic lesions, including follicular variant papillary carcinomas, based on nuclear morphology, immunohistochemical profiles, and molecular markers may pave the way for a better understanding of the biology of oncocytic lesions of the thyroid.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990587      PMCID: PMC1770246          DOI: 10.1136/jcp.2003.008474

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  56 in total

1.  Immunohistochemical diagnosis of papillary thyroid carcinoma.

Authors:  C C Cheung; S Ezzat; J L Freeman; I B Rosen; S L Asa
Journal:  Mod Pathol       Date:  2001-04       Impact factor: 7.842

2.  Flow cytometric measurements of nuclear DNA and ploidy analysis in Hürthle cell neoplasms of the thyroid.

Authors:  M K McLeod; N W Thompson; J L Hudson; J A Gaglio; R V Lloyd; J K Harness; R Nishiyama; P S Cheung
Journal:  Arch Surg       Date:  1988-07

3.  The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.

Authors:  Gennaro Chiappetta; Paolo Toti; Francesco Cetta; Ada Giuliano; Francesca Pentimalli; Ida Amendola; Stefano Lazzi; Mario Monaco; Luca Mazzuchelli; Piero Tosi; Massimo Santoro; Alfredo Fusco
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

Review 4.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

5.  Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.

Authors:  P L Fernández; M J Merino; M Gómez; E Campo; T Medina; V Castronovo; X Sanjuán; A Cardesa; F T Liu; M E Sobel
Journal:  J Pathol       Date:  1997-01       Impact factor: 7.996

6.  Hürthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study.

Authors:  M A Sobrinho-Simões; J M Nesland; R Holm; M C Sambade; J V Johannessen
Journal:  Ultrastruct Pathol       Date:  1985       Impact factor: 1.094

7.  Hürthle cell tumors: a twenty-five-year experience.

Authors:  M Arganini; R Behar; T C Wu; F Straus; M McCormick; L J DeGroot; E L Kaplan
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

8.  Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy.

Authors:  G Har-El; T Hadar; K Segal; R Levy; J Sidi
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

9.  Papillary Hürthle cell carcinoma with lymphocytic stroma. "Warthin-like tumor" of the thyroid.

Authors:  R L Apel; S L Asa; V A LiVolsi
Journal:  Am J Surg Pathol       Date:  1995-07       Impact factor: 6.394

10.  Hürthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior.

Authors:  M F Herrera; I D Hay; P S Wu; J R Goellner; J J Ryan; J R Ebersold; E J Bergstralh; C S Grant
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

View more
  19 in total

Review 1.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Hurthle cell follicular carcinoma of the thyroid gland presenting with diffuse meningeal carcinomatosis and evolving to anaplastic carcinoma.

Authors:  Carlo Maria Stucchi; Valentina Vaccaro; Anna Magherini; Carmela Di Gregorio; Gabriele Greco; Virginia A Livolsi; Giampaolo Papi
Journal:  J Clin Pathol       Date:  2007-07       Impact factor: 3.411

Review 3.  Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.

Authors:  Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

Review 4.  Hurthle Cell Lesion: Controversies, Challenges, and Debates.

Authors:  Michael Shawky; Mahmoud Sakr
Journal:  Indian J Surg       Date:  2015-10-30       Impact factor: 0.656

5.  Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.

Authors:  Shuting Bai; Zubair W Baloch; Teresa D Samulski; Kathleen T Montone; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

6.  The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.

Authors:  Inhwa Lee; Hyeung Kyoo Kim; Euy Young Soh; Jeonghun Lee
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

Review 7.  Hurthle cell carcinoma of the thyroid.

Authors:  Mark Anthony S Sandoval; Elizabeth Paz-Pacheco
Journal:  BMJ Case Rep       Date:  2011-02-09

Review 8.  Controversies in thyroid pathology: the diagnosis of follicular neoplasms.

Authors:  Stefano Serra; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

9.  Agonistic anti-CD40 induces thyrocyte proliferation and promotes thyroid autoimmunity by increasing CD40 expression on thyroid epithelial cells.

Authors:  Timothy Kayes; Yujiang Fang; Shiguang Yu; Edward Downey; Shufang Wang; Helen Braley-Mullen
Journal:  J Immunol       Date:  2013-03-15       Impact factor: 5.422

10.  Culture promotes transfer of thyroid epithelial cell hyperplasia and proliferation by reducing regulatory T cell numbers.

Authors:  Timothy D Kayes; Helen Braley-Mullen
Journal:  Cell Immunol       Date:  2013-09-18       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.